People Background Check
Find People:

Michael Vincent Tullius, Age 555229 Balboa Blvd, Van Nuys, CA 91316

Get Report
Known as:
Michael V Tullius Michael William Tullius Michael A Tullius Michael W Tullius Mike A Tullius Mike W Tullius Michael Tullious N Tullious
Related to:
Debtr Peters

Michael Tullius Phones & Addresses

5229 Balboa Blvd, Encino, CA 91316

1932 Overland Ave, Los Angeles, CA 90025 (310) 475-7451

San Francisco, CA

Rosemead, CA

175 Johnstone Dr APT 304, San Francisco, CA 94131

Work

Position: Executive, Administrative, and Managerial

Education

Degree: High school graduate or higher

Mentions for Michael Vincent Tullius

Career records & work history

Lawyers & Attorneys

Michael Tullius Photo 1

Michael Tullius - Lawyer

Office:
Michael J. Tullius
Specialties:
Probate, Guardianship, Domestic Relations
ISLN:
913676712
Admitted:
1972
University:
Oklahoma State University, B.A., 1968
Law School:
University of Oklahoma, J.D., 1972

Michael Tullius resumes & CV records

Resumes

Michael Tullius Photo 20

Michael Tullius

Michael Tullius Photo 21

Assistant Researcher At Ucla

Location:
Greater Los Angeles Area
Industry:
Research
Michael Tullius Photo 22

Editor At Tullius Editorial Services

Location:
Greater Los Angeles Area
Industry:
Publishing

Publications & IP owners

Us Patents

Recombinant Intracellular Pathogen Immunogenic Compositions And Methods Of Use

US Patent:
8124068, Feb 28, 2012
Filed:
Oct 19, 2009
Appl. No.:
12/581795
Inventors:
Marcus A. Horwitz - Los Angeles CA, US
Gunter Harth - Los Angeles CA, US
Michael V. Tullius - Encino CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01N 63/00
A01N 65/00
C12N 1/12
C12N 1/20
US Classification:
424 931, 424 932, 4352523, 4352531
Abstract:
Immunogenic compositions comprising recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens are provided. Exemplary immunogenic compositions include, but are not limited to attenuated recombinant expressing the major extracellular non-fusion proteins of and/or other intracellular pathogens. Other embodiments are provided wherein the recombinant attenuated intracellular pathogen is auxotrophic.

Growth Regulatable Recombinant Bcg Compositions

US Patent:
8163294, Apr 24, 2012
Filed:
Apr 10, 2007
Appl. No.:
12/296660
Inventors:
Marcus A. Horwitz - Los Angeles CA, US
Michael V. Tullius - Encino CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 39/04
A61K 39/02
A61K 49/00
US Classification:
4242481, 424 91, 424 92, 4241841, 4241921, 4242001, 4242341
Abstract:
Immunogenic compositions comprising growth regulatable recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens are provided. Exemplary immunogenic compositions include, growth regulatable and growth limited recombinant attenuated intracellular pathogen immunogenic compositions.

Immunostimulatory Recombinant Intracellular Pathogen Immunogenic Compositions And Methods Of Use

US Patent:
8383132, Feb 26, 2013
Filed:
Jan 7, 2011
Appl. No.:
12/986598
Inventors:
Marcus A. Horwitz - Los Angeles CA, US
Michael Tullius - Encino CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 39/04
A61K 48/00
C07H 21/04
US Classification:
4242481, 424 932, 536 231, 536 237
Abstract:
Immunogenic compositions comprising recombinant intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens and immunostimulatory molecules are provided. Exemplary immunogenic compositions include, but are not limited to, recombinant BCG expressing major extracellular proteins and immunostimulatory molecules.

Recombinant Intracellular Pathogen Vaccines And Methods For Use

US Patent:
2003012, Jul 3, 2003
Filed:
Sep 30, 2002
Appl. No.:
10/261981
Inventors:
Marcus Horwitz - Los Angeles CA, US
Gunter Harth - Los Angeles CA, US
Michael Tullius - Los Angeles CA, US
International Classification:
A61K039/00
A61K039/38
US Classification:
424/184100
Abstract:
Immunogenic compostions for inducing immune responses in an animal host against intracellular pathogen diseases are provided. The immunogenic compostions consist of recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens. Exemplary immunogenic compostions include, but are not limited to, vaccines and immunotherapeutics such as attenuated recombinant Mycobacteria expressing the major extracellular non-fusion proteins of Mycobacteria and/or other intracellular pathogens. These exemplary vaccines are shown to produce surprisingly potent protective immune responses in mammals.

Recombinant Intracellular Pathogen Immunogenic Compositions And Methods For Use

US Patent:
2004000, Jan 15, 2004
Filed:
May 15, 2003
Appl. No.:
10/439611
Inventors:
Marcus Horwitz - Los Angeles CA, US
Gunter Harth - Los Angeles CA, US
Michael Tullius - Encino CA, US
International Classification:
A61K039/00
A61K039/38
US Classification:
424/184100
Abstract:
Immunogenic compositions comprising recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens are provided. Exemplary immunogenic compositions include, but are not limited to attenuated recombinant Mycobacteria expressing the major extracellular non-fusion proteins of Mycobacteria and/or other intracellular pathogens. Other embodiments are provided wherein the recombinant attenuated intracellular pathogen is auxotrophic.

Recombinant Intracellular Pathogen Immunogenic Compositions And Methods For Use

US Patent:
2007012, Jun 7, 2007
Filed:
Oct 15, 2004
Appl. No.:
10/595385
Inventors:
Marcus Horwitz - Los Angeles CA, US
Gunter Harth - Los Angeles CA, US
Michael Tullius - Encino CA, US
International Classification:
A61K 39/116
A61K 39/04
US Classification:
424203100, 424248100
Abstract:
Immunogenic compositions comprising recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens are provided. Exemplary immunogenic compositions include, but are not limited to attenuated recombinant Mycobacteria expressing the major extracellular non-fusion proteins of Mycobacteria and/or other intracellular pathogens. Other embodiments are provided wherein the recombinant attenuated intracellular pathogen is auxotrophic.

Unmarked Recombinant Intracellular Pathogen Immunogenic Compositions Expressing High Levels Of Recombinant Proteins

US Patent:
2010018, Jul 22, 2010
Filed:
Jun 12, 2008
Appl. No.:
12/664485
Inventors:
Marcus A. Horwitz - Los Angeles CA, US
Michael V. Tullius - Encino CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 38/20
A61K 39/00
A61K 39/02
A61K 38/21
A61K 39/04
A61K 39/07
A61K 39/112
US Classification:
424 852, 4241841, 4242001, 424 855, 4242691, 4242731
Abstract:
Recombinant immunogenic compositions, and methods for the manufacture and use, are provided for the prevention and treatment of intracellular pathogen diseases in humans and animals. The recombinant immunogenic compositions express high levels of recombinant proteins in vectors that do not harbor an antibiotic resistance marker (“unmarked”).

Possible Relatives

Patrick D Tullius  Scott L Tullius  Michael A Last  Michael D Stanaland  Michael Stanberry  Michael A Stanbro  Michael W Stancil  Michael P Stanczak  Michael A Standley  Michael L Stanek 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.